ReviewPharmaceuticals (Basel, Switzerland)2024

Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment.

Paul Carrillo-Mora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.